Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 30.05
+0.65 (2.21%)
Aug 21, 2026, 3:00 PM CST
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 12.19 billion as of August 21, 2026. Its market cap has decreased by -9.29% in one year.
Market Cap
12.19B
Enterprise Value
12.48B
Revenue
759.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.05
ChartMarket Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 12.19B, a decrease of -24.60%. That is a compound annual growth rate of -5.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 12.19B | 18.43% |
| Dec 31, 2025 | 10.29B | 139.25% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
| Jun 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mabwell (Shanghai) Bioscience | 14.48B |
| Shanghai Medicilon | 14.47B |
| Jinyu Bio-technology | 14.17B |
| Nanjing Vazyme Biotech | 13.19B |
| InventisBio | 12.41B |
| Hualan Biological Vaccine | 12.05B |
| Tibet Cheezheng Tibetan Medicine | 11.72B |
| Staidson (Beijing) BioPharmaceuticals | 11.50B |